SynthoGraft®

Pure Phase Beta-Tricalcium Phosphate

Particle SizeVolumeVialsPart Number
50-500μm0.25g5260-400-125
50-500μm0.50g5260-400-150
50-500μm1.00g5260-400-151
50-500μm2.00g5260-400-152
500-1000μm0.25g5260-400-525
500-1000μm0.50g5260-400-500
500-1000μm1.00g5260-400-501
500-1000μm2.00g5260-400-502

Bone Graft Syringe

DescriptionPart Number
4.0mm Bone Graft Syringe260-801-510
5.0mm Bone Graft Syringe260-801-511

SynthoGraft® Considerations

Indications and Usage:

  • SynthoGraft® is designed for the filling and/or reconstruction of a traumatic or degenerative multi-walled bone defect, augmentation of the sinus floor, augmentation of alveolar ridges, filling of periodontal or other alveolar bone defects, tooth sockets, and osteotomies, and preservation of the alveolus for the preparation of an implant site.

Warnings:

  • SynthoGraft® should be used only by or under the supervision of trained personnel with experience with the surgical techniques associated with biomaterials.
  • SynthoGraft® is packaged and sterilized via gamma irradiation for single use only.
  • Do not apply SynthoGraft® dry. It must be wetted with the patient’s blood.
  • Do not saturate SynthoGraft® with any liquid other than the patient’s blood.
  • Do not re-sterilize SynthoGraft®.
  • Discard any unused SynthoGraft®t granulate. Re-use of SynthoGraft® may cause adverse reactions, including, but not limited to, infection, inflammation, or other injury.
  • SynthoGraft® is not intended for immediate loading.
  • Do not overfill defect site.
  • Secure SynthoGraft® to prevent migration of materials.
  • Do not use if package has been opened, damaged, or if the expiration date has passed.
  • Do not compromise blood supply to the defect area.
  • Any serious incident that has occurred in relation to the device should be reported to the manufacturer and the competent authority of the Member State in which the user and/or patient is established, if applicable.